ES2569619T3 - Péptidos contiguos superpuestos para el tratamiento de la alergia al polen de abedul - Google Patents

Péptidos contiguos superpuestos para el tratamiento de la alergia al polen de abedul Download PDF

Info

Publication number
ES2569619T3
ES2569619T3 ES10707962.6T ES10707962T ES2569619T3 ES 2569619 T3 ES2569619 T3 ES 2569619T3 ES 10707962 T ES10707962 T ES 10707962T ES 2569619 T3 ES2569619 T3 ES 2569619T3
Authority
ES
Spain
Prior art keywords
peptide
sec
allergic
subjects
reactivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10707962.6T
Other languages
English (en)
Spanish (es)
Inventor
Christophe Reymond
Francois Spertini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anergis SA
Original Assignee
Anergis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42358661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2569619(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anergis SA filed Critical Anergis SA
Application granted granted Critical
Publication of ES2569619T3 publication Critical patent/ES2569619T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES10707962.6T 2009-02-09 2010-02-09 Péptidos contiguos superpuestos para el tratamiento de la alergia al polen de abedul Active ES2569619T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US151045P 1999-08-27
US15104509P 2009-02-09 2009-02-09
PCT/IB2010/000393 WO2010089671A2 (fr) 2009-02-09 2010-02-09 Peptides contigus se chevauchant destinés au traitement de l'allergie au pollen de bouleau

Publications (1)

Publication Number Publication Date
ES2569619T3 true ES2569619T3 (es) 2016-05-11

Family

ID=42358661

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10707962.6T Active ES2569619T3 (es) 2009-02-09 2010-02-09 Péptidos contiguos superpuestos para el tratamiento de la alergia al polen de abedul

Country Status (12)

Country Link
US (2) US8343503B2 (fr)
EP (1) EP2393511B2 (fr)
JP (2) JP5566404B2 (fr)
AU (1) AU2010212039C1 (fr)
CA (1) CA2750705C (fr)
DK (1) DK2393511T4 (fr)
ES (1) ES2569619T3 (fr)
HR (1) HRP20160426T1 (fr)
HU (1) HUE027491T2 (fr)
PL (1) PL2393511T5 (fr)
SI (1) SI2393511T1 (fr)
WO (1) WO2010089671A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
WO2013001362A2 (fr) * 2011-06-27 2013-01-03 Anergis S.A. Peptides contigus se chevauchant destinés au traitement de l'allergie au pollen d'ambroisie
EP2746396A1 (fr) * 2012-12-20 2014-06-25 PLS-Design GmbH Inhibition sélective locale de fonctions liées au TNFR1 au niveau du site de présentation de l'antigène/allergène
EP3003366B1 (fr) * 2013-06-06 2020-08-05 Anergis S.A. Peptides contigus se chevauchant pour le traitement d'une allergie aux acariens de la poussière
US20200188511A1 (en) 2018-12-12 2020-06-18 Anergis S.A. Methods of improving efficacy of allergy vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1219299T4 (da) * 2000-12-28 2011-02-14 Biomay Ag Allergivacciner og fremstilling deraf
WO2004002415A2 (fr) 2002-06-27 2004-01-08 Dana-Farber Cancer Institute, Inc. Compositions et methodes de modulation d'une reponse immunitaire avec les lymphocytes t cytotoxiques
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
US20100226933A1 (en) † 2007-02-14 2010-09-09 Universitaet Salzburg Hypoallergenic proteins

Also Published As

Publication number Publication date
HRP20160426T1 (hr) 2016-07-29
JP5566404B2 (ja) 2014-08-06
US20100203070A1 (en) 2010-08-12
CA2750705C (fr) 2015-12-29
HUE027491T2 (en) 2016-10-28
SI2393511T1 (sl) 2016-10-28
CA2750705A1 (fr) 2010-08-12
PL2393511T3 (pl) 2016-11-30
DK2393511T3 (en) 2016-05-09
PL2393511T5 (pl) 2020-08-10
EP2393511B2 (fr) 2020-03-25
DK2393511T4 (da) 2020-04-27
WO2010089671A3 (fr) 2010-10-14
JP2014037438A (ja) 2014-02-27
EP2393511B1 (fr) 2016-04-06
WO2010089671A2 (fr) 2010-08-12
AU2010212039C1 (en) 2015-03-05
US8343503B2 (en) 2013-01-01
AU2010212039B2 (en) 2014-09-18
US20130156799A1 (en) 2013-06-20
AU2010212039A1 (en) 2011-07-28
JP2012517418A (ja) 2012-08-02
EP2393511A2 (fr) 2011-12-14

Similar Documents

Publication Publication Date Title
JP6640818B2 (ja) イエダニアレルギーの処置のための連続したオーバーラップペプチド
ES2698525T3 (es) Transportador de vacuna
ES2569619T3 (es) Péptidos contiguos superpuestos para el tratamiento de la alergia al polen de abedul
EP1219300A1 (fr) Vaccins contre l' allergie
Twaroch et al. Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy
ES2934129T3 (es) Vacuna conjugada dirigida a una proteína biológica causante de enfermedad
Ricciardi et al. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant
ES2532759T3 (es) Péptidos de plantas herbáceas para vacunas
EA034692B1 (ru) Улучшенные транспортные молекулы модулярного антигена и их применение
ES2526678T3 (es) Polipéptidos hipoalergénicos para el tratamiento de alergia contra ácaros del polvo doméstico
Igetei et al. Antigenic cross-reactivity between Schistosoma mansoni and pollen allergens from the birch tree (Betula verrucosa) and Timothy grass (Phleum pratense): involvement of shared glycan epitopes and implications for the hygiene hypothesis
CN104903347A (zh) 肽
US9005627B2 (en) Contiguous overlapping peptides for treatment of ragweed pollen allergy
JP4733022B2 (ja) 新規ダニアレルゲン
JP2017502977A (ja) アレルギー状態治療用組成物及び方法
DK2838556T3 (en) Plant profile polypeptides for use in non-specific allergy immunotherapy
US20070003579A1 (en) Allergen-specific immunotherapy
ES2238487T5 (es) Variantes de la proteina alergenica phl p1 de phleum pratense.
ES2307381B1 (es) Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
ES2738636T3 (es) Composición para la administración intradérmica de alergenos polimerizados
AU2014352986A1 (en) Pan pollen immunogens and methods and uses thereof for immune response modulation
OA17915A (en) Compositions for use in the treatment of allergic conditions.
ES2439617A1 (es) Composición para la administración intradérmica de alergoides